UKCAEU MDR / IVDRFDAPortfolio management
Established & multi-product teams

One standard. Every product.
Every market.

Regi's intelligent workflows help established SaMD and AI device teams manage change, scale compliance across a portfolio, and stay audit-ready across UKCA, EU MDR and FDA.

Try Regi free or talk to us

Keep submissions consistent

Across products, markets, and teams.

Turn change into a controlled update

Without rewrites or fire drills.

Operationalise PMS and evidence

AI-powered adverse event triage and trend analysis keep you audit-ready.


The challenge

Compliance gets harder as you scale.

The challenge isn't knowing the rules. It's keeping everything aligned and current.

Once you have multiple products, multiple markets, and multiple teams, definitions drift between documents, evidence lives in different places, and changes in product, data sources, or AI behaviour ripple into claims, risk controls, labelling, PMS and reporting.

That's when organisations get hit by avoidable rework: inconsistent intended purpose wording across markets, duplicated evidence efforts, patchwork PMS activities, audit fire drills, and slowdowns when expanding indications or launching new versions.


What makes Regi different

Built for portfolio-scale regulatory operations

Consistent intelligence across every team

AI Assist works the same way for every team member across every product — same hazard suggestions, same gap checks, same guideline grounding — so audit posture doesn't depend on who ran the workflow.

Portfolio consistency, not one-off documents

Each product lives in its own device-specific workspace with isolated data. The Traceability Hub and Essential Requirements Matrix (GSPR) link hazards to controls and verification consistently across every product, so each team builds on the same foundation rather than reinventing it.

Change-aware execution

When the product evolves, Document Wizards guide you through updating the affected sections of PMS plans, clinical evaluation reports, and risk management files. Regi keeps your narrative coherent across submissions, PMS and technical documentation without a manual audit of every linked artefact.

Explainable and audit-ready by default

Capture decision logic as you go, maintain version history, and produce structured outputs that stand up to internal review, notified bodies and auditors.

Fits your existing stack

Regi doesn't replace your QMS/RIM. It's the execution layer that keeps your regulatory work connected, consistent, and easier to run at scale.


Deliverables

What Regi gives you

The building blocks for consistent, scalable regulatory execution across your entire portfolio.

Standardised Intended Purpose across product lines and markets
Consistent classification reasoning and traceability
Evidence plans reusable and linked to each product version
PMS with adverse event triage and portfolio-wide trend analysis
Change notes that stay coherent across releases
Defensible audit trail across the entire portfolio

Regi Portfolio A Acme Health AI Product Portfolio FDA EU MDR UKCA All CardioSense AI UKCA Class IIb · SaMD Intended Purpose 100% Risk & Hazards 80% Clinical Eval. 45% PMS 10% Overall 59% Active NeuroDx Platform EU MDR Class III · AI Diagnostic Intended Purpose 100% Risk & Hazards 100% Clinical Eval. 90% PMS 70% Overall 90% In review PulseCheck FDA 510(k) Class II · De Novo Intended Purpose 60% Risk & Hazards 20% Clinical Eval. 0% PMS 0% Overall 20% Early stage 3 Products · 3 frameworks 2 On track 14 Apr NeuroDx next deadline

Process

How Regi works

01
Select the device from your portfolio dashboard

All products on one dashboard. Each sits in its own isolated workspace — data never leaks between products or markets.

02
Document Wizards keep every team consistent

Guided wizards keep every team consistent across PMS plans, clinical evaluations, and risk files, regardless of individual experience.

03
Inputs propagate across modules automatically

Product-specific context flows automatically across risk, evidence, traceability, and PMS per device.

04
Traceability and PMS run continuously across the portfolio

Traceability and requirements links update automatically as each product evolves. PMS monitoring runs in the background portfolio-wide.

05
Adverse events triaged, trends monitored portfolio-wide

AI triages adverse events per device and monitors signals across the portfolio, surfacing issues before they compound.

06
Consistent human review across every team

Review and approve every AI suggestion — across every team member and every product in the portfolio.

Intended Purpose Risk & Hazards Evidence Plan Portfolio PMS Product data stays isolated · flows consistently across every module · portfolio stays audit-ready

Ready to scale?

Build a compliance operation that scales with your portfolio.

See how Regi handles your portfolio structure — book a demo with your products in mind.

Try Regi free Talk to the team
0
Skip to Content
Regi - Intelligent compliance.
Regi - Intelligent compliance.
Meet Regi
Start ups and early stage
Multi-Product Teams
Consulting and Advisory
Get in touch
Regi - Intelligent compliance.
Regi - Intelligent compliance.
Meet Regi
Start ups and early stage
Multi-Product Teams
Consulting and Advisory
Get in touch
Meet Regi
Start ups and early stage
Multi-Product Teams
Consulting and Advisory
Get in touch

Contact ‍Sustainability‍ ‍Privacy‍ ‍Cookies‍ ‍Terms of use‍ ‍Accessibility

© 2026. Regi Digital Ltd.
Registered in England & Wales.
Company Number 16914302